1. Apoptosis
    Protein Tyrosine Kinase/RTK
  2. MDM-2/p53
    Apoptosis
    ROS Kinase
  3. Anticancer agent 42

Anticancer agent 42 

Cat. No.: HY-146516
Handling Instructions

Anticancer agent 42 (compound 10d) is an orally active anticancer agent, and shows a potent antitumor activity against MDA-MB-231 cell with an IC50 of 0.07 μM. Anticancer agent 42 can exert its anticancer activity by activating apoptotic pathway and p53 expression. Anticancer agent 42 can be used to study metastatic breast cancer.

For research use only. We do not sell to patients.

Anticancer agent 42 Chemical Structure

Anticancer agent 42 Chemical Structure

CAS No. : 2687265-18-3

Size Stock
100 mg   Get quote  
250 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Anticancer agent 42 (compound 10d) is an orally active anticancer agent, and shows a potent antitumor activity against MDA-MB-231 cell with an IC50 of 0.07 μM. Anticancer agent 42 can exert its anticancer activity by activating apoptotic pathway and p53 expression. Anticancer agent 42 can be used to study metastatic breast cancer[1].

IC50 & Target

IC50: 0.07 μM (Anticancer in MDA-MB-231 cell)[1]

In Vitro

Anticancer agent 42 (compound 10d) (0-20 μM, 4 h) exhibits a potent antitumor activity against MDA-MB-231 cells[1].
Anticancer agent 42 (10 μM, 24 h) induces G2 and S phase arrest in MDA-MB-231 cells[1].
Anticancer agent 42 (10 μM, 24 h) induces cell apoptosis by regulating the expression of apoptosis related proteins in MDA-MB-231 cells[1].
Anticancer agent 42 (0-1 μM) depolarizes mitochondrial membrane and decreases the mitochondrial membrane potential leading to apoptosis[1].
Anticancer agent 42 (0-1 μM, 24 h) induces the cells to produce a large amount of ROS[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay

Cell Line: A549, MDA-MB-231, HeLa[1]
Concentration: 0-20 μM
Incubation Time: 4 h
Result: Exhibited a potent activity against MDA-MB-231 with an IC50 of 0.07 μM.

Cell Cycle Analysis

Cell Line: MDA-MB-231 cells[1]
Concentration: 10 μM
Incubation Time: 24 h
Result: Induced G2 and S phase arrest in MDA-MB-231 cells; caused the percentage of MDA-MB-231 cells in G1 phase to decrease significantly (from 74.44% to 16.48%), cells in G1 phase to increase (from 16.61% to 28.47%), and in G2 phase to significantly increase (from 8.95% to 55.05%).

Apoptosis Analysis

Cell Line: MDA-MB-231 cells[1]
Concentration: 10 μM
Incubation Time: 24 h
Result: Induced cell apoptosis, with apoptotic rate of 31.69%.

Western Blot Analysis

Cell Line: MDA-MB-231 cells[1]
Concentration: 100 nM
Incubation Time: 48 h
Result: Increased the level of human apoptosis-related proteins (pro-caspase 3, catalase, HTRA2/Omi and p53) in MDA-MB-231 cell.

Western Blot Analysis

Cell Line: MDA-MB-231 cells[1]
Concentration: 0, 0.035, 0.07, 0.14, 0.21 μM
Incubation Time: 24 h
Result: Increased caspase 9, caspase3, cytochrome C and Bax expression, but decreased Bal-2 expression with increasing concentration.
In Vivo

Anticancer agent 42 (compound 10d) (Kunming mice, 5000 mg/kg, Intragastric administration, once) has extremely low oral toxicity[1].
Anticancer agent 42 (Kunming mice, 238-600 mg/kg, IP, once) shows no obvious liver and kidney damage to mice, with an LD50 of 374 mg/kg[1].
Anticancer agent 42 (Kunming mice, 25 mg/kg, IP, once every two days) causes mild liver and kidney damage[1].
Anticancer agent 42 (BALB/c mice, suppresses breast cancer 4T1 tumor growth, the anti-tumor effect is better combined use with CA (Cyanoacrylates), and can cross through the skin to achieve anti-tumor effects.[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Kunming mice (n=10, 5 male and 5 female)[1]
Dosage: 5000 mg/kg
Administration: Intragastric administration, once
Result: Had extremely low oral toxicity, did not cause death in mice at 5000 mg/kg.
Animal Model: Kunming mice[1]
Dosage: 600, 476, 378, 300, 238 mg/kg
Administration: IP, once
Result: Showed no obvious liver and kidney damage to mice, with an LD50 of 374 mg/kg.
Animal Model: Kunming mice (n=3)[1]
Dosage: 25 mg/kg
Administration: IP, once every two days
Result: Caused mild liver and kidney damage after administration, slightly increased ALT, AST and BUN of mice.
Animal Model: BALB/c mice (4T1 tumor-bearing, female, eight groups, 6 mice per group)[1]
Dosage: 10d (50 mg/kg) + CA; 10d (50 mg/kg) + saline; 10d (200 mg/kg) + CA
Administration: Intratumoral injection, every four days (50 mg/kg); smear, every two days (200 mg/kg), for 14 days.
Result: Showed obvious antitumor effect from the 8th day; had protective effects on the spleens of tumor-bearing mice; the anti-tumor effect is better when combined use with CA; can cross through the skin to achieve anti-tumor effects.
Molecular Weight

391.25

Formula

C19H16Cl2N2O3

CAS No.
SMILES

CC1=C(C2=CC=CC=C2N1)C3=C(C(C(Cl)=C(C3=O)N4CCOCC4)=O)Cl

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email address *

Phone number *

 

Organization name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Anticancer agent 42
Cat. No.:
HY-146516
Quantity:
MCE Japan Authorized Agent: